Auchus RJ - Search Results

1

Androstenedione is the preferred androgen source in hormone refractory prostate cancer--letter.

Sharifi N, Auchus RJ. Sharifi N, et al. Among authors: auchus rj. Clin Cancer Res. 2014 Sep 15;20(18):4971. doi: 10.1158/1078-0432.CCR-14-1123. Clin Cancer Res. 2014. PMID: 25225065 No abstract available.

2

3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.

Evaul K, Li R, Papari-Zareei M, Auchus RJ, Sharifi N. Evaul K, et al. Among authors: auchus rj. Endocrinology. 2010 Aug;151(8):3514-20. doi: 10.1210/en.2010-0138. Epub 2010 Jun 9. Endocrinology. 2010. PMID: 20534728

3

"Getting from here to there"--mechanisms and limitations to the activation of the androgen receptor in castration-resistant prostate cancer.

Sharifi N, McPhaul MJ, Auchus RJ. Sharifi N, et al. Among authors: auchus rj. J Investig Med. 2010 Dec;58(8):938-44. doi: 10.231/JIM.0b013e3181ff6bb8. J Investig Med. 2010. PMID: 21030877 Free PMC article. Review.

4

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.

Chang KH, Li R, Papari-Zareei M, Watumull L, Zhao YD, Auchus RJ, Sharifi N. Chang KH, et al. Among authors: auchus rj. Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13728-33. doi: 10.1073/pnas.1107898108. Epub 2011 Jul 27. Proc Natl Acad Sci U S A. 2011. PMID: 21795608 Free PMC article.

5

Steroid biosynthesis and prostate cancer.

Sharifi N, Auchus RJ. Sharifi N, et al. Among authors: auchus rj. Steroids. 2012 Jun;77(7):719-26. doi: 10.1016/j.steroids.2012.03.015. Epub 2012 Apr 5. Steroids. 2012. PMID: 22503713 Review.

6

Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.

Li R, Evaul K, Sharma KK, Chang KH, Yoshimoto J, Liu J, Auchus RJ, Sharifi N. Li R, et al. Among authors: auchus rj. Clin Cancer Res. 2012 Jul 1;18(13):3571-9. doi: 10.1158/1078-0432.CCR-12-0908. Clin Cancer Res. 2012. PMID: 22753664

7

Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer.

Ferraldeschi R, Sharifi N, Auchus RJ, Attard G. Ferraldeschi R, et al. Among authors: auchus rj. Clin Cancer Res. 2013 Jul 1;19(13):3353-9. doi: 10.1158/1078-0432.CCR-12-0931. Epub 2013 Mar 7. Clin Cancer Res. 2013. PMID: 23470964 Free PMC article. Review.

8

A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.

Chang KH, Li R, Kuri B, Lotan Y, Roehrborn CG, Liu J, Vessella R, Nelson PS, Kapur P, Guo X, Mirzaei H, Auchus RJ, Sharifi N. Chang KH, et al. Among authors: auchus rj. Cell. 2013 Aug 29;154(5):1074-1084. doi: 10.1016/j.cell.2013.07.029. Cell. 2013. PMID: 23993097 Free PMC article.

9

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.

Li Z, Bishop AC, Alyamani M, Garcia JA, Dreicer R, Bunch D, Liu J, Upadhyay SK, Auchus RJ, Sharifi N. Li Z, et al. Among authors: auchus rj. Nature. 2015 Jul 16;523(7560):347-51. doi: 10.1038/nature14406. Epub 2015 Jun 1. Nature. 2015. PMID: 26030522 Free PMC article.

10

The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.

Capper CP, Rae JM, Auchus RJ. Capper CP, et al. Among authors: auchus rj. Horm Cancer. 2016 Jun;7(3):149-64. doi: 10.1007/s12672-016-0259-0. Epub 2016 Mar 11. Horm Cancer. 2016. PMID: 26969590 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters